Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1760)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (14)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4178)
  2. Weinberg Fellows (2759)
  3. Hematologic Malignancies, Division of (2494)
  4. Solid Tumor Oncology Division (2427)
  5. Center for Hematologic Malignancies (1946)
  6. GSK Faculty (1881)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (349)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (359)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4497)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and tissue concordance of BRCA2 copy number loss evaluated by single-cell, shallow whole genome sequencing of circulating tumor cells (CTCs) in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Barnett, E.; Schonhoft, J.; Schultz, N. D.; Lee, J.; Zaidi, S.; Abida, W.; Carmichael, T.; Dago, A. E.; Solit, D. B.; Wenstrup, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients
    Meeting Abstract

    Barrios, D. M.; Wang, D. G.; Blinder, V. S.; Bromberg, J.; Drullinsky, P.; Funt, S. A.; Jhaveri, K. L.; Lake, D.; Lyons, T.; Modi, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Defining patient-elicited concepts unique to adolescents and young adults with cancer
    Meeting Abstract

    Avutu, V.; Lynch, K.; Barnett, M.; Vera, J.; Glade Bender, J. L.; Tap, W. D.; Atkinson, T. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small-cell lung cancer and a poor performance status
    Meeting Abstract

    Alessi, J. V. M.; Ricciuti, B.; Aguilar, E. J.; Hong, F.; Wei, Z.; Nishino, M.; Plodkowski, A. J.; Sawan, P.; Luo, J.; Rizvi, H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • COVID-19 in patients with lung cancers in New York City
    Meeting Abstract

    Luo, J.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Hoyos, D.; Bandlamudi, C.; Donoghue, M. T. A.; Łuksza, M.; Greenbaum, B. D.; Wolchok, J. D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Targeting melanoma metabolism to overcome resistance to treatment
    Meeting Abstract

    Betoff, A.; Zippin, J.; Merghoub, T.; Chapman, P. B.; Wolchok, J.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A pan-cancer analysis of double PIK3CA mutations
    Meeting Abstract

    Vasan, N.; Sivakumar, S.; Jin, D.; Ross, J. S.; Cantley, L. C.; Scaltriti, M.; Sokol, E. S.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Suboptimal real-world (RW) outcomes for BRAF+ metastatic melanoma (MM) patients in 2L therapy (The NOBLE study series)
    Meeting Abstract

    Tarhini, A. A.; Betof Warner, A.; Johnson, M.; Kang, B.; Nakasato, A.; Vance, M.; Ling, Y. L.; Tang, J.; Patel, J.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Real world (RW) sequencing outcomes with immunotherapy and targeted therapy (TT) in BRAF+ metastatic melanoma (The NOBLE study series)
    Meeting Abstract

    Betof Warner, A.; Tarhini, A. A.; Johnson, M.; Kang, B.; Nakasato, A.; Vance, M.; Ling, Y. L.; Tang, J.; Patel, J.
    Annals of Oncology (2020)

    Fulltext@MSK | Save